Literature DB >> 12215693

Clinical profile of leptospirosis in South gujarat.

A M Clerke1, A C Leuva, C Joshi, S V Trivedi.   

Abstract

BACKGROUND: South Gujarat has been witnessing increasing incidence of leptospirosis for the last few years. AIM: To study the clinical profile of leptospirosis in South Gujarat. SETTINGS AND
DESIGN: Prospective study during July-September 2000 at the New Civil Hospital, Surat, Gujarat. PATIENTS AND METHODS: All the consecutive cases with clinical suspicion of leptospirosis were screened for lgM antileptospira antibody on the first and the fourteenth day. A four fold or greater increase in agglutinin antibody titre on paired samples was considered diagnostic. If the patient died before the fourteenth day then initial titre greater than 1:15 was considered diagnostic.
RESULTS: Total number of patients referred to the hospital were fifty, of which thirty-eight [33 males, with age 14-50 (30 +/- 10.51)] were diagnosed as having leptospirosis. Most common organs involved were liver (27, 71.05%) and kidney (24, 63.15%). Cardio-vascular (12, 31.5%), pulmonary (10, 26.35%), neurological (2, 5.26%) and haematological (8, 21%) involvements were less common. Six patients died because of pulmonary involvement in the form of alveolar haemorrhage, while one died because of cardiac involvement.
CONCLUSION: Liver and kidney were the most commonly involved organs in severe leptospirosis. Pulmonary involvement, though uncommon, led to high mortality.

Entities:  

Mesh:

Year:  2002        PMID: 12215693

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  6 in total

1.  Determinants of mortality and impact of therapy in patients with leptospirosis admitted for intensive care in a Sri Lankan hospital--a three year retrospective study.

Authors:  P N Weeratunga; S Fernando; S Sriharan; M Gunawardena; S Wijenayake
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

2.  Clinical profile, management and outcome of patients with leptospirosis during the times of COVID-19 pandemic: A prospective study from a tertiary care centre in South India.

Authors:  Nitin Gupta; William Wilson; Prithvishree Ravindra; Sowmya Joylin; Rachana Bhat; Kavitha Saravu
Journal:  Infez Med       Date:  2021-09-10

3.  Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis.

Authors:  Samir V Trivedi; Ashwin H Vasava; Tinkal C Patel; Lovleen C Bhatia
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun

4.  Developing a clinically relevant classification to predict mortality in severe leptospirosis.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Rashan Haniffa
Journal:  J Emerg Trauma Shock       Date:  2010-07

5.  Clinical and laboratory manifestation and outcome of icterohemorrhagic leptospirosis patients in Northern Iran.

Authors:  Shahriar Alian; Alireza Davoudi; Narges Najafi; Roya Ghasemian; Fatemeh Ahangarkani; Zeinab Hamdi
Journal:  Med J Islam Repub Iran       Date:  2015-12-15

6.  Increasing trends of leptospirosis in northern India: a clinico-epidemiological study.

Authors:  Sunil Sethi; Navneet Sharma; Nandita Kakkar; Juhi Taneja; Shiv Sekhar Chatterjee; Surinder Singh Banga; Meera Sharma
Journal:  PLoS Negl Trop Dis       Date:  2010-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.